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Genome instability is a hallmark of cancer cells. One class of genome aberrations prevalent in tumor cells is termed
gross chromosomal rearrangements (GCRs). GCRs comprise chromosome translocations, amplifications, inversions,
deletion of whole chromosome arms, and interstitial deletions. Here, we report the results of a genome-wide screen in
Saccharomyces cerevisiae aimed at identifying novel suppressors of GCR formation. The most potent novel GCR
suppressor identified is BUD16, the gene coding for yeast pyridoxal kinase (Pdxk), a key enzyme in the metabolism of
pyridoxal 59 phosphate (PLP), the biologically active form of vitamin B6. We show that Pdxk potently suppresses GCR
events by curtailing the appearance of DNA lesions during the cell cycle. We also show that pharmacological inhibition
of Pdxk in human cells leads to the production of DSBs and activation of the DNA damage checkpoint. Finally, our
evidence suggests that PLP deficiency threatens genome integrity, most likely via its role in dTMP biosynthesis, as
Pdxk-deficient cells accumulate uracil in their nuclear DNA and are sensitive to inhibition of ribonucleotide reductase.
Since Pdxk links diet to genome stability, our work supports the hypothesis that dietary micronutrients reduce cancer
risk by curtailing the accumulation of DNA damage and suggests that micronutrient depletion could be part of a
defense mechanism against hyperproliferation.
Citation: Kanellis P, Gagliardi M, Banath JP, Szilard RK, Nakada S, et al. (2007) A screen for suppressors of gross chromosomal rearrangements identifies a conserved role for
PLP in preventing DNA lesions. PLoS Genet 3(8): e134. doi:10.1371/journal.pgen.0030134
Introduction
The faithful replication of the genome is necessary for
maintenance of genome integrity. Disrupting processes that
ensure faithful DNA replication results in chromosome
breakage, hyper-recombination, or gross chromosomal rear-
rangements (GCRs) [1–3]. This relationship has been partic-
ularly highlighted in the budding yeast S. cerevisiae, where
GCRs arise at high rates in cells with defects in the S-phase
checkpoint [4], DNA replication licensing [5,6], DNA repli-
cation elongation [7–9], chromatin assembly [10], and
homologous recombination (HR) repair [8].
Altogether, these studies not only suggest a common
origin (i.e., DNA replication), but also a common mechanism
by which genome rearrangements are formed [2]. Defects
that occur during DNA replication lead to elevated levels of
DNA damage, including DNA double-strand breaks (DSBs).
In turn, these lesions may serve as substrates for the
illegitimate repair processes resulting in GCRs. Therefore,
identiﬁcation of genes that prevent GCRs can potentially
uncover novel genome caretakers that guard cells against the
accumulation of mutations. In addition, unbiased identi-
ﬁ c a t i o no fG C Rs u p p r e s s o r sc o u l db eau s e f u lr o u t ef o r
discovering novel genes and pathways that participate in
DNA replication.
Most of the current knowledge regarding GCR formation
originates from candidate gene studies examining rearrange-
ments at a single locus in budding yeast, the left arm of
Chromosome V (ChrV-L). Although this locus has been
instrumental in the deciphering of many basic mechanisms
governing genome stability in eukaryotes, examination of
GCR formation at other loci provides a complementary view.
For example, the use of yeast artiﬁcial chromosomes to study
GCRs led to the discovery that defective chromosome
condensation (in a ycs4 mutant) results in GCR events [7]. In
addition, studies employing a Chromosome VII disome found
that defects in DNA replication and checkpoint control
elevate rates of chromosome loss and rearrangements
following replication fork stalling [11]. In another study,
Hackett et al. employed the telomeric region of ChrXV-L to
study GCR events triggered by telomerase dysfunction [12].
This latter locus is particularly useful since GCRs at ChrXV-L
involve break-induced replication (BIR), a type of homolo-
gous recombination repair predicted to be a major source of
genome rearrangements [2,13–15]. In contrast, GCRs formed
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addition [8]. This difference can be explained by the
architecture of the telomere-proximal region on ChrXV-L,
which contains two regions of homology (HRI centered on
the PAU20 gene, and HRII centered on the HXT11 gene;
Figure 1A) located 12 kb and 25 kb from the telomere [12].
These regions share a high degree of sequence identity with
other regions in the genome [12]. As a consequence, DNA
lesions formed at loci telomeric to HRI or HRII are
predominantly repaired by BIR, producing nonreciprocal
translocations in haploid cells. Notably, increased repair by
BIR can also lead to loss of heterozygosity in diploid genomes,
which may accelerate the process of tumorigenesis by
inactivation of tumor suppressor genes.
In this study, we screened the yeast genome for mutants
that increase the level of chromosome rearrangements;
speciﬁcally, those that increase the frequency of BIR-
mediated nonreciprocal translocations. We report the
construction of a strain containing a GCR reporter on
ChrXV-L that is amenable to genome-wide screening and
compatible with synthetic genetic array technology [16]. We
employed this strain to systematically screen the gene
deletion collection [17] leading to the identiﬁcation of nine
new GCR suppressors. Here, we focus on the character-
ization of one of the most potent GCR suppressors
identiﬁed, BUD16, which encodes yeast pyridoxal kinase
(Pdxk), a critical enzyme in vitamin B6 metabolism. We show
that Pdxk is critical for the maintenance of genome integrity
via its role in maintaining adequate levels of pyridoxal 59
phosphate (PLP), the biologically active form of vitamin B6.
Our results are consistent with a model whereby dTMP
biosynthesis is the pathway affected by a decrease in PLP,
thus providing an important link between dietary micro-
nutrients, DNA replication and genome stability. Further-
more, since many epidemiological studies have linked
defective vitamin B6 levels to an increased cancer incidence
[18–23], our study supports the hypothesis that micro-
nutrients such as vitamin B6 curtails carcinogenesis by
preventing genomic instability.
Results
A System for the Facile Recovery of BIR-Mediated GCR
Events
To generate a GCR reporter strain that is amenable to
genome-wide screening, we adapted a system previously
described by Hackett et al. [12]. We inserted the CAN1 and
URA3 genes, two counter-selectable markers, ;10 kb from
the telomere of ChrXV-L (Figure 1A). The simultaneous loss of
CAN1 and URA3 (detected on media containing canavinine
[can] and 5-ﬂuoro-orotic acid [5-FOA]) at this locus occurs at
a rate of 8.9 3 10
 8 (Table 1), approximately 250-fold higher
than the rate observed at ChrV-L (3.5 3 10
 10; Table 2). This
elevated GCR rate may be due to the higher efﬁciency of BIR
over de novo telomere addition in repairing DSBs. Moreover,
the HRI and HRII regions on ChrXV-L display between 85%–
97% homology with a total of 21 chromosome arms [12]. This
large number of potential seeds for BIR may also explain the
relatively high GCR rate at ChrXV-L. To ensure that the GCR
events recovered from the simultaneous loss of CAN1 and
URA3 are due to BIR, we analyzed GCR events in wild-type
cells by pulsed-ﬁeld gel electrophoresis (PFGE) using a
scheme described by Hackett et al. [12]. Brieﬂy, we isolated
genomic DNA from parental can
S 5-FOA
S cells and cells that
have undergone GCR events at ChrXV-L (can
R 5-FOA
R cells).
This DNA is then digested with PmeI to liberate a terminal
restriction fragment, separated by PFGE, and ﬁnally trans-
ferred onto nitrocellulose by Southern blotting to be probed
with a ChrXV-L-speciﬁc fragment (NOP8; Figure 1B). If BIR
occurs by employing any of the 21 homologous chromosome
arms as a template, the resulting terminal restriction frag-
ments liberated by PmeI are all predicted to be of lower
molecular weight than the parent fragment (;97 kb). As
predicted, the analysis of nine can
R 5-FOA
R mutants derived
from the wild-type strain indicate that nine out of nine have
undergone a GCR event at ChrXV-L that is consistent with
BIR, since their terminal restriction fragments all migrate
faster than that of the parental strain (Figure 1B). Further-
more, the analysis of four can
R 5-FOA
R strains by compara-
tive genome hybridization using tiling microarrays identiﬁed
breakpoints either in HRI, in the vicinity of the PAU20 gene
(in two of four strains analyzed), or in HRII (i.e., in the vicinity
of the HXT11 genes, two of four strains; see Figure 1C for two
representative examples). Lastly, we determined the GCR rate
at ChrXV-L of a rad52D strain, since RAD52 is required for
BIR. The rad52D strain does not produce any detectable GCR
events under the standard conditions of our assay (i.e., the
rate must be  8.4 3 10
 9; Table 2). This result suggests that
most of GCR events observed at ChrXV-L are indeed
dependent on RAD52, a gene required for BIR. Collectively,
the above results indicate that the ChrXV-L GCR reporter
monitors BIR-type events.
A Genome-Wide Screen for Suppressors of BIR-Mediated
GCR Events
We crossed the resulting ChrXV-L GCR assay strain with the
4,812 viable open reading frame deletion strains [16,17] and
employed a semi-quantitative papillation assay to monitor
GCR formation (Figure S1). An initial set of 48 strains that
scored positive were reconstructed in the ChrXV-L assay
strain to determine their GCR rate by ﬂuctuation analysis [24]
(Table 1). This group included deletions in several known
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e134 1439
A Screen for Suppressors of Genome Rearrangements
Author Summary
Cells must ensure the integrity of genetic information before cellular
division. Loss of genome integrity is particularly germane to
tumorigenesis, where it is thought to contribute to the rapid
evolution of the malignant cell towards the fully cancerous
phenotype. It is therefore imperative that we understand fully
how cells maintain the integrity of the genome and how it is lost
during tumorigenesis. In this study, we developed an assay that
allowed us to systematically interrogate each gene of the budding
yeast S. cerevisiae for its respective contribution to genome integrity.
We report the identification of nine novel genes that increase the
rate of genome instability in yeast when deleted. To our surprise,
one of the genes we identified encodes the enzyme pyridoxal
kinase, which acts in the metabolism of vitamin B6. We show that
pyridoxal kinase influences genome stability by promoting the
conversion of dietary vitamin B6 into its biologically active form,
pyridoxal 59 phosphate. Our work indicates that vitamin B6
metabolites are critical to maintain genome stability and supports
a long-standing model, which hypothesizes that vitamin B6 reduces
cancer risk by curtailing genome rearrangements.GCR suppressors such as the genes encoding Mre11, a
component of the MRX complex, the RecQ helicase Sgs1,
and the budding yeast FEN-1 homolog, Rad27. Using this
scheme, we identiﬁed nine gene deletions that display at least
a 10-fold increase in GCR rate compared to wild type (Table 1
and Figure 2A). Of these nine novel GCR suppressors,
mutations in RMI1, RAD5, SLX8, and HEX3 were independ-
ently reported during the course of this study to promote
GCRs at ChrV [25–27].
The remaining ﬁve novel GCR suppressors include BUD16,
WSS1, ESC2, RML2, and ZIP1. Intriguingly, ZIP1 encodes a
component of the synaptonemal complex that is active
Figure 1. The ChrXV-L GCR Assay
(A) Schematic of the ChrXV-L GCR reporter chromosome. A GCR event in this region of ChrXV-L can result in the loss of the URA3 and CAN1 genes, which
yields a canavanine and 5-FOA resistant strain (can
R 5-FOA
R). PSF3 is the first essential gene on ChrXV-L. HRI and HRII denote two regions of homology
that are centered around the PAU20 and HXT11 genes, respectively.
(B) PFGE analysis of ChrXV-L terminal restriction fragments following PmeI digestion of genomic DNA isolated from either the parent strain (W) or strains
that have undergone a GCR event (1–9). Asterisk indicates incomplete digestion products of ChrXV.
(C) Array-based comparative genome hybridization of two strains that have undergone a GCR event at ChrXV-L. The above panel is a histogram
representation of log2-tranformed relative signal enrichments on Chromosome XV viewed in the University of California Santa Cruz genome browser
[69]. The location of the array probes (reporters) is also indicated. Note the large loss of sequences on the left arm of ChrXV in both strains. The lower
panel zooms to the ChrXV-L subtelomeric region. The breakpoint in strain (i) must be in the vicinity of the PAU20 gene (YOL161C), whereas that of strain
(ii) resides in the vicinity of HXT11.
doi:10.1371/journal.pgen.0030134.g001
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e134 1440
A Screen for Suppressors of Genome Rearrangementsduring meiosis [28] and is also expressed in mitotic cells [29],
suggesting a potential role for Zip1 in mitotic genome
stability. RML2 encodes the mitochondrial L2 ribosomal
protein [30]. Surprisingly, a Rml2-GFP fusion protein local-
izes to the nucleus [31], suggesting a putative nuclear function
for Rml2. WSS1 encodes a weak suppressor of an smt3
mutation [32], and ESC2 encodes a protein harboring a
SUMO domain that has been linked to heterochromatic
silencing [33,34] and the function of the Smc5/6 complex [35].
BLAST searches and alignments reveal that BUD16 encodes a
putative Pdxk. With a GCR rate of 1.1 3 10
 5 (124-fold above
wild type), bud16D is within the range of very potent GCR
mutator deletions that include rad27D (1.3 3 10
 5; 148-fold
over wild-type rate), mre11D (1.3 3 10
 5; 140-fold), and sgs1D
(1.2310
 5; 129-fold) (Figure 2A and Table 1). Reintroduction
of a plasmid encoding wild-type BUD16 complemented the
genome instability of bud16D cells, eliminating the possibility
that a second site mutation contributes to its elevated GCR
rate (Figure 2B). We also examined the type of GCR events
promoted by the bud16D mutation by PFGE, which indicated
that BUD16 prevents BIR-type rearrangements at ChrXV-L
(Figure 2C). Given that bud16D had the most profound effect
on genome stability among the uncharacterized suppressors,
we focused on deciphering its role in preventing chromo-
some rearrangements.
BUD16 Encodes the Yeast Pyridoxal Kinase
In all organisms, Pdxk is an essential component of a
vitamin B6 salvage pathway that ultimately produces PLP [36].
To ascertain whether BUD16 functions as the budding yeast
Pdxk, we measured PLP levels in wild-type and bud16D strains.
We found that the PLP levels of bud16D cells are only 1.8% of
wild-type levels (Table 3). This result is somewhat surprising,
since bacteria, yeast, and plants also possess a de novo vitamin
B6 pathway that produces PLP in a Pdxk-independent
manner. In yeast, this pathway is under the control of the
SNO1 and SNZ1 genes [37]. However, these genes are not
normally expressed during logarithmic growth but rather are
expressed during stationary phase or under poor nutrient
conditions. We found that the simultaneous deletion of the
SNO1 and SNZ1 locus did not signiﬁcantly reduce PLP levels
(95.2% of wild-type levels; Table 3) or increase GCR rates
Table 1. GCR Rates of Mutants Identified from the Genome-Wide
GCR Papillation Assay
Gene
ORF
Gene
Name
GCR Rate (6 SEM) Fold Difference
over Wild Type
YPL024W RMI1 4.5 3 10
 5 6 2 3 10
 6 506
YKL113C RAD27 1.3 3 10
 5 6 6 3 10
 6 148
YMR224C MRE11 1.3 3 10
 5 6 5 3 10
 7 140
YMR190C SGS1 1.2 3 10
 5 6 3 3 10
 6 129
YEL029C BUD16 1.1 3 10
 5 6 1 3 10
 6 124
YGL258W
a RAD6 7.7 3 10
 6 6 4 3 10
 7 87
YER116C SLX8 7.6 3 10
 6 6 2 3 10
 6 86
YCR066W
a RAD18 5.1 3 10
 6 6 3 3 10
 7 57
YDL013W HEX3 4.3 3 10
 6 6 2 3 10
 7 48
YHR134W WSS1 3.3 3 10
 6 6 6 3 10
 7 37
YDR363W ESC2 2.9 3 10
 6 6 7 3 10
 7 32
YLR032W RAD5 2.8 3 10
 6 6 3 3 10
 7 31
YEL050C RML2 2.1 3 10
 6 6 9 3 10
 7 24
YDR285W ZIP1 9.1 3 10
 7 6 7 3 10
 8 10
YHR167W THP2 5.3 3 10
 7 6 9 3 10
 8 6
YLR234W TOP3 5.1 3 10
 7 6 3 3 10
 7 6
YBR035C PDX3 4.2 3 10
 7 6 8 3 10
 8 5
YNL107W YAF9 3.2 3 10
 7 6 5 3 10
 8 4
YIL139C REV7 2.4 3 10
 7 6 6 3 10
 8 3
YGL235W YGL235W 2.1 3 10
 7 6 5 3 10
 8 2
YOR015W YOR015W 2.0 3 10
 7 6 6 3 10
 8 2
YPR044C YPR044C 1.9 3 10
 7 6 9 3 10
 8 2
YDR286C YDR286C 1.5 3 10
 7 6 2 3 10
 7 2
YDL162C YDL162C 1.4 3 10
 7 6 4 3 10
 8 2
YER095W
a RAD51 9.3 3 10
 8 6 4 3 10
 8 1
Wild-type — 8.9 3 10
 8 6 3 3 10
 9 1
YML032C
a RAD52 ,8.4 3 10
 9 6 1 3 10
 9b ,0.09
Deletion of these genes produces a wild-type GCR rate: BBC1*, BUD25, ESC8*, FRE7*,
GTR11, HUT1, NPT1, PCL2, PHO80, REV1, RCO1*, SNF5*, UBC4*, YSA1*, YBL009W, YBR027C*,
YDL063C*, YDL109C, YDL133W*, YLR326W1, YMR130W*, YOL153C*, YOR111W*, YPL077C*,
YPR038W*, and YPR045C (asterisk indicates a single measurement).
Mutants of the following genes were not measured: ARO7, BEM4, BUD28, CTA1, CTK3,
CWC27, DON1, ESC4, FIG1, FUN9, GAL1, GDH3, GIR2, HAP3, HAP5, HIS6, IES6, ISR1, LTP1,
MCH5, MUD1, NGG1, NRG2, PLC1, RAD50*, RPL16B, RPS10A, RNR4, RSA1, RTG3, RTS3, SHU1*,
SIP4, SFL1, SLX9, SNC1, SNU66, SPT2, SPT7, SPT8, SRD2, STE13, TAF14, THI21, TIR2, TIR4, TPI1,
TRP4, UAF30, URA5, XRS2*, YAL018C, YAL037W, YBL012C, YBL028C, YBL046W, YDL062W,
YDL124W, YDR104C, YER087W, YER121W, YGR011W, YHR168W, YJL083W, YLR235C,
YML084W, YML087C, YMR087W, YNL089C, YOR011W, YOR135C, YOR223W, YPL062W,
YPL176C, YPL245W, YPL260W, and YSC83 (asterisk indicates genes known to increase
GCRs).
aThese mutants were not identified in the screen, but were assayed for GCR rates
bNo colonies were recovered in the rad52D mutant GCR assay; therefore, we estimate the
GCR rate based on the total number of cells plated and the minimum rate that would be
observed if we saw one colony on FC.
ORF, open reading frame; SEM, standard error of the mean.
doi:10.1371/journal.pgen.0030134.t001
Table 2. ChrXV-L and ChrV-L GCR Rates of Vitamin B6 Mutants
Mutant Strain GCR RATE ( 6 S.E.) Fold Difference
over Wild Type
ChrXV-L wild type 8.9 3 10
 8 6 1 3 10
 6 1
a
bud16D 1.1 3 10
 5 6 8 3 10
 7 124
tpn1D 4.2 3 10
 6 6 7 3 10
 7 47
bud16D tpn1D 1.1 3 10
 5 6 5 3 10
 7 124
sno1snz1D 6.1 3 10
 8 6 1 3 10
 8 0.7
snz1D 1.1 3 10
 8 6 1 3 10
 9 0.1
bud16D þ
pRS415 (SC-LEU)
1.3 3 10
 6 6 1 3 10
 7 75
b
bud16D þ
pRS415-BUD16 (SC-LEU)
1.7 3 10
 8 6 6 3 10
 9 1
b
tpn1D sno1snz1D 1.7 3 10
 5 6 7 3 10
 6 191
tpn1D sno1snz1D þ
2 lg/ml pyridoxine
1.1 3 10
 8 6 5 3 10
 10 0.1
ChrXV-L wild type þ
20 mM NAC
2.5 3 10
 7 6 1 3 10
 7 1
c
bud16D þ 20 mM NAC 1.3 3 10
 4 6 5 3 10
 6 520
c
bud16Drad52D 2.4 3 10
 8 6 9 3 10
 9 0.3
rad52D ,8.4 3 10
 9 6 1 3 10
 9d ,0.09
ung1D 1.5 3 10
 7 6 3 3 10
 8 2
ung1Dbud16D 1.9 3 10
 5 6 7 3 10
 6 213
ChrV-L wild type 3.5 3 10
 10 6 2 3 10
 10 1
e
ChrV-L bud16D 6.5 3 10
 9 6 8 3 10
 10 19
e
aEach mutant, unless otherwise stated, was compared to this measurement to calculate
fold difference. All mutants were grown in XY (rich media) unless otherwise stated.
bThese mutants were grown in SC-LEU and GCR rates were compared to each other.
cThese mutants were grown in XY with 20 mM NAC and GCR rates were compared.
dNo colonies were recovered in the rad52D mutant GCR assay; therefore, we estimate the
GCR rate based on the total number of cells plated and the minimum rate that would be
observed if we saw one colony on FC.
eThese mutants were examined in the ChrV-L GCR assay and GCR rates were compared to
one another.
doi:10.1371/journal.pgen.0030134.t002
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A Screen for Suppressors of Genome Rearrangements(Table 2). Although SNO1 and SNZ1 deletion did not
signiﬁcantly impact genome stability (or PLP levels) in
BUD16 cells, the de novo vitamin B6 synthetic pathway is
nevertheless essential for viability in the absence of BUD16.
Indeed, we are unable to recover viable triple mutants from a
cross between bud16D and sno1snz1D or double mutants from
a cross between bud16D and snz1D (Figure 2D). Overall, the
decrease in intracellular PLP levels in bud16D along with its
synthetic lethality with sno1snz1D are consistent with the idea
that BUD16 functions in parallel with the de novo B6
pathway as a yeast pyridoxal kinase. Additional character-
ization of the bud16D strain in terms of growth and cell cycle
kinetics is described in Text S1 and in Figure S2 and Tables
S1 and S2.
BUD16 Prevents Genomic Instability at Multiple Genomic
Loci
To determine whether the bud16D mutation increases
genome instability across the genome, we calculated the
GCR rate of a bud16D strain at the ChrV-L locus [8]. We found
that the bud16D mutation elevates the GCR rate at this locus
19-fold over the wild-type rate (Figure 3A; Table 2). Analysis
of the GCR events involving ChrV by whole-chromosome
PFGE reveals a mixture of events consistent with de novo
telomere additions (six out of eight events analyzed) and
nonreciprocal translocations (two out of eight events) (Figure
3B). This ratio of telomere additions to translocations (4:1) is
similar to the ratio of GCRs typically recovered from a wild-
type strain [4]. Together, these results indicate that BUD16
suppresses different types of genome rearrangements at a
Figure 2. A Genome-Wide Screen Identifies BUD16 as a Key Determinant for Genome Stability in S. cerevisiae
(A) GCR rates at ChrXV-L of the indicated strains. The data is presented as the fold-increase over the wild-type GCR rateþ/ strandard error of the mean.
Asterisk refers to genes with high GCR rates that were not identified in the screen, but were measured during the course of this study.
(B) A plasmid encoding BUD16 suppresses the high GCR rate of bud16D.
(C) PFGE analysis of ChrXV-L terminal restriction fragments following PmeI digestion of genomic DNA isolated from either the wild-type (W), parent
bud16D strains (B), or bud16D strains that have undergone a GCR event (1–8). Asterisk indicates incomplete digestion products of ChrXV.
(D) The bud16D mutation is synthetic lethal with the deletions of SNO1 and SNZ1.
doi:10.1371/journal.pgen.0030134.g002
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A Screen for Suppressors of Genome Rearrangementsminimum of two different loci in the genome, suggesting that
BUD16 may act to prevent the occurrence of DNA lesions
rather than by promoting a speciﬁc type of illegitimate
repair.
To further characterize the mechanism that underlies the
high GCR rate of bud16D cells in the ChrXV-L assay, we
crossed the bud16D GCR reporter strain to a strain containing
a deletion of RAD52, a gene necessary for all types of
homologous recombination, including BIR [15]. The GCR
rate at ChrXV-L of the bud16D rad52D double mutant was
reduced to wild-type levels (2.4310
 8; Table 2). However, this
rate is far greater than the GCR rate of a rad52D mutation
alone (,,8.4 3 10
 9; Table 2). Furthermore, analysis of the
terminal restriction fragment of the rearranged chromo-
somes in the bud16D rad52D double mutant shows terminal
deletions in seven out of eight cases that are strikingly larger
than those observed in either wild-type or bud16D strains (23–
37 kb shorter in rad52D strains versus ;7–17 kb in the
RAD52
þ strains; Figure 4A and 4B). This difference in the size
of the ChrXV-L terminal restriction fragment suggests that
bud16D rad52D do not undergo BIR-mediated GCR events
that employ the HRI/II regions as seeds. Instead, in the
absence of functional HR, these mutants are likely repaired
by de novo telomere additions, leading to large terminal
deletions.
Elevated Levels of DNA Lesions and Activation of the DNA
Damage Checkpoint in bud16D Cells
Together, the observations that BUD16 suppresses GCRs at
multiple loci in a BIR-dependent and independent manner
suggest that bud16D cells experience higher-than-normal levels
of DNA lesions during vegetative growth. We ﬁnd support for
this possibility when tetrads from a cross between bud16D and
rad52D are examined (Figure 5A). We observe that the bud16D
rad52D double mutant displays synthetic sickness and poor
viability when compared to their congenic single mutants. This
result suggests that bud16D cells may experience high levels of
genotoxic stress that require the HR pathway for optimum
viability. Consistent with this explanation, the bud16D muta-
tion also displays synthetic sickness when crossed with an
MRE11 gene deletion and to a lesser extent with deletion of
RAD51, two additional genes acting in the homologous repair
of DSBs (Figure 5A). We also observe a strong genetic
interaction between the bud16D and rad6D mutations (Figure
5A), suggesting that DNA lesions caused by the reduction of
PLP levels may require post-replicative repair or lesion bypass.
Based on this spectrum of genetic interactions, bud16D cells
likely accumulate DNA lesions during DNA replication,
possibly leading to replication fork stalling or collapse.
To gain more direct evidence for the presence of active
RAD52-dependent recombination in bud16D cells, we moni-
tored the formation of Rad52 DNA repair centers [38]. Upon
formation of lesions that engage HR, Rad52 relocalizes from a
diffuse nuclear pattern into discernable punctate foci that
coincide with DNA lesions. We thus expressed a Rad52
protein fused to the yellow ﬂuorescent protein (YFP) in wild-
type and bud16D cells and examined the presence of Rad52
repair centers by ﬂuorescent microscopy (Figure 5B). In
bud16D cultures, 37%–75% of the cells display Rad52-YFP
foci compared to 5%–21% of wild-type cells (Figure 5B). In
bud16D cultures, Rad52-YFP foci are surprisingly found in G1
(unbudded) cells but are most prevalent in S/G2/M (budded)
cells (57%–75% in budded versus 37%–59% in unbudded
cells). Intriguingly, the presence of Rad52 foci in G1 nuclei
suggests the presence of persistent or unrepairable DNA
lesions in cells that have undergone checkpoint adaptation
[39]. Furthermore, we observe that budded bud16D cells
Figure 3. Deletion of BUD16 Also Increases GCR Formation at ChrV-L
(A) GCR rate of either the wild-type (WT) or bud16D strain at ChrV-L.
(B) Whole-chromosome PFGE analysis of wild-type (W), parental bud16D (B), or bud16D strains that have undergone a GCR event (1–8). Left panel:
ethidium bromide–stained gel. Right panel: Southern blot with a ChrV-specific probe (MCM3).
doi:10.1371/journal.pgen.0030134.g003
Table 3. Levels of Vitamin B6 (PLP) Measured by HPLC
Strain % PLP 6 SD Relative to
Wild-Type Levels
a
Wild type 100.0 6 8
snz1sno1D 95.2 6 6
tpn1D 8.0 6 3
bud16D 1.8 6 0.6
tpn1D snz1sno1D þ 0 lg/ml pyridoxine 5.8 6 2
tpn1D snz1sno1D þ 2 lg/ml pyridoxine 81.5 6 7
aThe average PLP level for wild type is 4,797 nM.
SD, standard deviation.
doi:10.1371/journal.pgen.0030134.t003
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whereas this situation occurs in less than 2% of wild-type cells
(Figure 5C). Since up to ten DSBs may localize to one repair
centre [38], these results suggest that bud16D cells experience
high levels of DNA lesions during DNA replication. Alter-
natively, we cannot exclude the possibility that bud16D cells
have a dramatically reduced rate of DNA repair. However,
bud16D cells are not sensitive to the radiomimetic alkylating
agent methyl methanesulfonate (MMS; Figure 5D), indicating
that the Rad52 pathway is functional in these cells. Therefore,
the increased presence of Rad52 foci in bud16D cells is most
likely explained by an increased number of DNA lesions.
Next, we examined whether the spontaneous DNA damage
present in bud16D cells is sufﬁcient to activate the DNA
damage checkpoint pathway by assaying Rad53, the yeast
homolog of the tumor suppressor Chk2. Rad53 kinase
activation is observed by a detectable auto-kinase activity
[40] concomitant with a reduced mobility on SDS-PAGE due
to autophosphorylation. As shown in Figure 5E, Rad53 is
hyperactivated in bud16D cells when compared to wild type,
indicating that sufﬁcient DNA damage is present in the
bud16D mutant to activate the DNA damage checkpoint.
Phosphorylation of Rad53 in cycling populations is often seen
in strains that experience high levels of spontaneous DNA
lesions, such as dia2D, rrm3D, and rmi1D, among others
[25,41,42]. Altogether, our results are consistent with a model
whereby bud16D cells experience high levels of DNA lesions,
including DSBs. These DNA lesions most likely serve as
substrates for illegitimate repair, resulting in elevated levels
of genome rearrangements.
Normal PLP Levels Are Required for Genome Integrity
The genome instability observed in the bud16D mutant
correlates with low levels of PLP. However, this observation
Figure 4. Homologous Recombination Is Required for the BIR-Mediated GCR Events in bud16D Cells
(A) PFGE analysis of ChrXV-L terminal restriction fragments following PmeI digestion of genomic DNA isolated from either the wild-type (W), parent
bud16Drad52D strains (BR), or bud16Drad52D strains that have undergone a GCR event (1–8). Asterisk indicates incomplete digestion products of ChrXV.
An undigested Chromosome XV likely explains the presence of a signal in the well of strain 8, although a weak TRF signal can be detected.
(B) Quantitation of the terminal restriction fragment length decrease following GCRs when the PmeI TRFs from bud16D and bud16Drad52D cells are
compared to those of wild type.
TRF, terminal restriction fragment.
doi:10.1371/journal.pgen.0030134.g004
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phenotype could be due to a PLP-independent function of
Bud16/Pdxk. To address this possibility, we aimed to reduce
PLP levels by alternative means to probe the relationship
between PLP and genome integrity. As a ﬁrst means, we
inactivated other components of the vitamin B6 salvage
pathway. In particular, when yeast are grown to log phase
under laboratory conditions, the PLP precursor, pyridoxine,
is actively transported into cells mainly, but not solely, by the
Tpn1 transporter [43]. Therefore, we asked whether TPN1
deletion impacts total PLP levels and genome stability. Cells
harboring a tpn1D mutation have low levels of intracellular
PLP (8% of wild-type; Table 3) that are nevertheless higher
than those of bud16D. At a genetic level, we ﬁnd that the tpn1D
mutation is not synthetic lethal with the sno1snz1D double
mutant (Figure 6A). The continued viability of the tpn1D
sno1snz1D mutant supports the observation that although
Tpn1 is a component of the B6 salvage pathway, it is not
absolutely essential for pyridoxine transport [43]. Accord-
ingly, the GCR rate of the tpn1D strain at ChrXV-L is increased
47-fold over the wild-type rate, which is less that of the
bud16D GCR rate (124-fold over wild type; Figure 6B).
However, both genes act in the same pathway to suppress
genome rearrangements, as the double bud16D tpn1D mutant
display the same GCR rate as bud16D (Figure 6B). Lastly, we
ﬁnd multiple Rad52 recombination centers present in 4%–
7% of tpn1D budded cells, suggesting the presence of
catastrophic DNA damage similar to that seen in bud16D,
albeit at a lower level (Figure 6C). Altogether, these results
further suggest that PLP levels correlate with genome
integrity.
In addition to manipulating PLP levels via genetic means,
we also manipulated pyridoxine intake to further explore the
link between PLP levels and genome integrity. To carry out
these experiments, we disabled de novo vitamin B6 synthesis
(via SNO1 SNZ1 inactivation) to exclude the contribution of
this pyridoxine-independent pathway. We also impaired
pyridoxine transport by deleting TPN1. When grown in rich
media, the resulting tpn1D sno1snz1D triple mutant has an
elevated GCR rate (191-fold over wild type), which is greater
than either the tpn1D or sno1snz1D mutants (Table 2).
Accordingly, when we measure the PLP levels of this strain,
we ﬁnd that they are 5.8% of wild-type levels (Table 3).
Importantly, we then supplemented the growth media of
tpn1D sno1snz1D with 2 lg/ml pyridoxine as a means to
stimulate its transport across the membrane. As shown in
Figure 6D and Table 2, addition of pyridoxine to the media of
tpn1D sno1snz1D potently suppresses its GCR rate to wild-type
levels. Critically, under the same conditions, the PLP levels of
the tpn1D sno1snz1D strain are dramatically increased to
81.5% of wild type (Figure 6E; Table 3). Together, these data
conclusively demonstrate a relationship between PLP levels
and maintenance of genome integrity.
Pharmacological Inhibition of Pdxk in Human Cells Causes
DNA DSBs
We next examined the role of Pdxk on the genome
integrity of human cells by employing the well-characterized
vitamin B6 analog 4-deoxypyridoxine (4-DP) [44]. First, we
determined whether inhibition of human Pdxk leads to DNA
damage, particularly DSBs. To detect DSBs in human cells, we
examined the localization of 53BP1, a DNA repair and
signaling protein, by immunoﬂuorescence microscopy. 53BP1
forms nuclear foci that colocalize with DSBs in mammalian
cells and is thus a useful surrogate marker of this type of DNA
damage [45]. As shown in Figure 7A and 7B, addition of 4-DP
to the media of HeLa cells causes an accumulation of 53BP1
foci. Second, we found that 4-DP treatment also triggers
activation of the checkpoint kinase Chk2, as evidenced by
phosphorylation of its Thr68 residue (Figure 7C). Third, we
analyzed the phosphorylation status of H2AX on its C-
terminal Ser139 residue (known as c-H2AX), one of the
earliest events in the response to DSBs. The presence of c-
H2AX was assessed via immunoblotting (Figure 7C) and ﬂow
cytometry (Figure 7D) [46]. In cells treated with the Pdxk
inhibitor 4-DP, c-H2AX clearly accumulates during S-phase
between the 2N and 4N DNA content, similar to what is
observed in yeast cells (with Rad52-YFP). Importantly, to
ensure that the described effects were not due to apoptotic
effects caused by Pdxk inhibition at the concentrations of 4-
DP employed above, we measured levels of apoptosis in HeLa
cells by annexin V staining (Figure S3). From this data, we can
rule out the possibility that 4-DP triggers DSB formation via
the activation of an apoptotic program. Instead, our results
indicate that, as in yeast cells, Pdxk inhibition induces DNA
lesions and activation of the DNA damage response.
PLP May Affect dTMP Biosynthesis to Impact Genome
Stability
We ﬁnally sought to narrow down the biological pathway in
which PLP acts to promote genome stability. This is a difﬁcult
task, since PLP is a critical cofactor for numerous essential
enzymes acting in amino acid and dTMP biosynthesis.
However, our observations in yeast and human cells indicate
a role for PLP in preventing DNA lesions during DNA
replication, pointing to dTMP synthesis as the likeliest
candidate pathway linking PLP to genome stability (Figure
8A). This possible association is strengthened by the multi-
tude of observations that link dTMP biosynthesis to genome
integrity in both prokaryotes and eukaryotes (reviewed in
[47]). In this context, PLP deﬁciency may either cause
Figure 5. The BUD16 Gene Deletion Causes DNA Lesions and Checkpoint Activation
(A) Tetrad analysis of crosses between bud16D and rad52D, rad51D, mre11D,o rrad6D.
(B) Micrographs of wild-type (WT) or bud16D cells expressing Rad52-YFP. Left panels: differential interference contrast (DIC). Right panels: YFP
fluorescence microscopy (YFP). Arrowheads point to Rad52-YFP foci.
(C) Quantitation of Rad52-YFP foci per cell. Three independent isolates were examined with over 180 cells per isolate counted.
(D) Survival curves of wild-type, bud16D or rad52D cells serially diluted and plated onto rich mediaþ/ MMS (as indicated) and grown for 3–8 d at 30 8C
in triplicate. Percent survival at a given MMS concentration represents the number of colony-forming units of the indicated strain divided by the colony-
forming units of the wild type plated on media lacking MMS. No viable rad52D colonies were recovered at concentrations above 0.015% MMS.
(E) bud16D cells engage the DNA damage checkpoint. Upper panel: Rad53 immunoblots of extracts of the indicated strains. Middle panel: Ponceau stain
for loading control. Lower panel: Rad53 activity assessed by auto-kinase assays [40]. The immunoblot and auto-kinase assays were performed on the
same extracts.
doi:10.1371/journal.pgen.0030134.g005
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tide imbalance that impairs DNA replication fork stability, or
both. We therefore sought to assess the involvement of PLP in
dTMP biosynthesis by testing whether bud16D cells accumu-
late uracil nucleotides in their DNA. To do so, we employed a
recently described modiﬁed aldehydic slot blot assay that
detects abasic sites produced when isolated DNA is treated
with a uracil glycosylase enzyme [48]. As shown in Figure 8B,
strains lacking Pdxk (bud16D) accumulate uracil in their
genome signiﬁcantly more than their wild-type counterparts.
This accumulation is likely to be biologically important, as it
is in the same range as the uracil accumulation observed in
cells deﬁcient in uracil glycosylase (ung1D cells), the main
enzyme dedicated to the removal of uracil in DNA (Figure
8C). Furthermore, the double ung1D bud16D mutant accumu-
lates more uracil in its genome than either of the single
mutants, suggesting that UNG1 and BUD16 function in
separate pathways to prevent uracil incorporation into
DNA. These results are therefore consistent with a model in
which the bud16D mutation increases dUMP pools, thereby
increasing the frequency of dUTP incorporation into DNA.
Accumulation of uracil in genomic DNA may lead to DSB
accumulation and attendant genome instability via excision
of uracil and production of excessive abasic sites. However,
deletion of UNG1 does not suppress the bud16D genome
instability rate and in fact results in a GCR rate increase
(Table 2). This result indicates that either uracil excision is
not a major cause of DNA damage in cells with low PLP levels,
Figure 6. PLP Levels Correlate with Genome Stability
(A) Tetrad analysis of tpn1D (square) crossed to sno1snz1D (circle). Viable triple mutant tpn1D sno1snz1D can be recovered (circle in square).
(B) GCR rates at ChrXV-L of the indicated strains.
(C) Quantitation of Rad52-YFP foci per cell in wild-type and tpn1D cells.
(D) GCR rates at ChrXV-L of tpn1D sno1snz1D triple mutant grown with pyridoxine (þPYR) or without added pyridoxine to the media.
(E) Relative PLP levels of the tpn1D sno1snz1D triple mutant grown with pyridoxine (þPYR) or without added pyridoxine to the media.
doi:10.1371/journal.pgen.0030134.g006
PLoS Genetics | www.plosgenetics.org August 2007 | Volume 3 | Issue 8 | e134 1447
A Screen for Suppressors of Genome Rearrangementsthat an alternative excision pathway is involved, or that it is
the accumulation of uracil that poses a threat to replication
fork progression. Alternatively, it is also possible that a
nucleotide pool imbalance caused by dUTP accumulation is a
source of replication stress in bud16D cells. If bud16D cells
have a defect in maintaining nucleotide pools, they may
display some form of sensitivity to hydroxyurea (HU) a
ribonucleotide reductase inhibitor. As shown in Figure 8D,
HU dramatically affects the growth of bud16D cells at all
concentrations tested and also leads to inviability of bud16D
at 0.2 M HU, as measured by a colony-forming assay (Table
S3). In contrast and as discussed above, bud16D cells are
resistant to MMS, a DNA alkylating agent that causes DNA
replication stress by impeding replication fork progression
[49] (Figure 5D). Therefore, bud16D cells are sensitive to the
depletion of deoxyribonucleotides rather than to replication
stress. From these results, we suggest that PLP deﬁciency
triggers DNA lesions due to a nucleotide imbalance resulting
from defects in dTMP biosynthesis.
Discussion
A Genome-Wide Screen for Suppressors of Chromosome
Rearrangements at ChrXV-L
In this report, we describe a screen for suppressors of
rearrangements at ChrXV-L, a locus producing chromosome
aberrations primarily via BIR. Since this locus is different
from the commonly used ChrV-L locus, we expected over-
lapping and distinct sets of genes with those already known to
prevent rearrangements of ChrV. Indeed, comparison of the
results of our screen with a similar screen undertaken using
the ChrV-L reporter chromosome [50] identiﬁes only two
overlapping GCR suppressor genes, RAD5 and MRE11. This
lack of overlap between both screens indicates that neither
screen was saturating or that both loci can identify distinct
classes of genome stability regulators. Indeed, we observed
that disruption of some genes (such as SGS1) potently affects
the GCR rate at the ChrXV-L locus while having a much more
modest effect at ChrV [51], indicating that some genes may
speciﬁcally suppress BIR.
In addition to Pdxk (Bud16), most of the other genes
identiﬁed in our screen are likely to prevent DNA replication
stress, suggesting that an unbiased screen for GCR suppres-
sors is a potentially fruitful means of discovering novel
activities inﬂuencing DNA replication. In particular, deletion
of WSS1, which encodes a potential protease acting in the
SUMO pathway [52], is synthetic lethal with deletion of SGS1,
the yeast RecQ homolog [53]. This result, coupled with the
high GCR rate of the wss1D strain, suggests that Wss1, perhaps
via its proteolytic activity, acts in the management of DNA
replication forks to prevent their demise. Likewise, Esc2 likely
participates in maintaining replication fork integrity and
tolerance to replication stress, given the ascribed role of its
Figure 7. Inhibition of Pdxk Causes DSBs in Human Cells
(A) HeLa cells display elevated levels of 53BP1 foci following inhibition of Pdxk by 4-DP.
(B) Quantitation of cells with 53BP1 foci following 4-DP treatment.
(C) 4-DP treatment activates the DNA damage checkpoint in HeLa cells as measured by Chk2 phospho-Thr68 and c-H2AX immunoblotting.
(D) SiHa cells treated with 4-DP accumulate c-H2AX in S-phase, as measured by flow cytometry.
doi:10.1371/journal.pgen.0030134.g007
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Perhaps more puzzling is our identiﬁcation of ZIP1, a meiotic
gene, and RML2, encoding a mitochrondrial ribosome
component, as GCR suppressors. Therefore, this study
revealed several novel GCR regulators, which may be part
of several less well-understood GCR suppression pathways. It
will be important to decipher whether the products of these
genes do indeed participate in the maintenance of mitotic
genome integrity.
Yeast as a System to Study the Influence of Micronutrients
on Genome Stability
The link between decreased intracellular PLP levels and
genome stability is important, since vitamin B6 deﬁciency
correlates with heightened cancer risk [18–23]. This work
therefore provides support for a model whereby subnormal
levels of vitamin B6 may promote cancer development by
engendering DNA lesions and attendant genome rearrange-
ments. Given the poorly understood link between diet and
cancer incidence, the ChrXV-L GCR assay provides a simple
genetic system to probe the consequences of micronutrient
deﬁciency on genome stability. Although the potential link
between vitamin B6 and chromosome breakage had been
suggested previously [20], the lack of a genetically tractable
system to study the role of micronutrients in genome
integrity has prevented a deﬁnitive mechanistic explanation
of the vitamin B6–cancer epidemiological link. This situation
has led to a multitude of alternative explanations. For
example, other groups have contended that PLP decreases
cellular proliferation or protects cells from oxidative stress
[55,56]. We directly tested the possibility that reactive oxygen
species affect the GCR rate of bud16D cells by growing them
in the presence of the reactive oxygen species scavenger N-
acetylcysteine (NAC). To our surprise, treatment with this
compound increased rather than decreased the bud16D GCR
rate (Table 2), indicating that reactive oxygen species may not
play a major role in the formation of genome rearrangements
when PLP levels are low.
A Physiological Role for Intracellular Micronutrient
Depletion?
Replication stress is thought to be a major deleterious
event, as it is a source of DNA lesions and genome
rearrangements. Paradoxically, recent observations point to
a beneﬁcial role for replication stress as an innate defense
mechanism against tumorigenesis. Indeed, replication stress
Figure 8. PLP levels Are Required for Optimal dTMP Biosynthesis
(A) The intersection of vitamin B6 and dTMP biosynthesis. (i) Dietary vitamin B6 (i.e., pyridoxine) is imported into the cell via the Tpn1 transporter (S.
cerevisiae gene names in brackets). (ii) Pdxk phosphorylates the B6 vitamers (pyridoxine, pyridoxamine, and pyridoxal) to generate PLP, which acts (iii) as
a cofactor for serine hydroxymethyl transferase (SHMT). (iv) SHMT is necessary for the formation of methylenetetrahydrofolate (CH2¼THF), the methyl
group donor for the conversion of dUMP into dTMP. (v) A deficiency in PLP is predicted to reduce dTMP levels leading to a nucleotide pool imbalance
and incorporation of uracil into DNA.
(B) bud16D cells accumulate uracil in DNA, as measured by a modified aldehydic slot blot assay. The results of the slot blot (bottom panel) were
quantified and shown in the graph. IDV refers to the integrated density values of the bands.
(C) Uracil accumulation in the bud16D genomic DNA is comparable to that observed in ung1D DNA.
(D) bud16D cells are sensitive to nucleotide depletion by hydroxyurea at 0.2 M. The results of a colony forming assay can also be found in Table S3.
doi:10.1371/journal.pgen.0030134.g008
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erating cells [57,58]. In this context, replication stress leads to
activation of a DNA damage response that initiates sen-
escence, thereby stopping the growth of a potential tumor
[57–61]. These observations suggest that cells are wired to
produce DNA lesions when their proliferation is aberrantly
stimulated. One key and unresolved question that emerges
from this body of work pertains to the nature of the cellular
processes that trigger replication stress in response to
uncontrolled cell growth. We speculate that our work, which
links depletion of PLP to replication-associated DNA lesions,
provides a simple mechanism that could link hyperprolifera-
tion to the activation of the DNA damage response. Indeed,
we hypothesize that the exhaustion of metabolites through
unscheduled anabolic processes may be primarily sensed as
DNA replication stress. It will therefore be interesting to see
whether intracellular PLP levels are decreased in precancer-
ous lesions or whether Pdxk inhibition can sensitize cells to
oncogene-induced cellular senescence.
Materials and Methods
Plasmid construction. The CAN1 gene from strain BY4741 was
ampliﬁed from genomic DNA and cloned next to the URA3MX gene
marker in the BglII site of pAG60 [62] to yield DDp418. To construct
pBUD16 (DDp626), the BUD16 locus encompassing the BUD16 open
reading frame was ampliﬁed by PCR from yeast genomic DNA and
cloned in pCR2.1-TOPO (Invitrogen, http://www.invitrogen.com) and
sequenced. The BUD16 locus was then excised with SpeI and NotI and
cloned into the SpeI and NotI sites of pRS415.
Strain construction. To construct the GCR assay strain (DDY643)
the CAN1 gene of BY4741 strain was replaced with the MFA1pr-HIS3
marker [16]. This strain was then transformed with a PCR fragment
containing the cycloheximide-resistance cyh2 marker to yield strain
DDY642. The CAN1-URA3 cassette was ampliﬁed from DDp418 with
primers CAN1-URA3 F1: 59-GAA TCT GCC GTT TCG ATT TAC
TTC GAT AAA GTT TGC GTT GTG AGT CAT ACG GCT TTT
TTG-39 and CAN1-URA3 JM R1: 59-GGA AAA TTC TGG TCT ATT
CAC AAT GAC AAG CGG TGA GCG TGT ATA GCG ACC AGC
ATT CAC-39 (underlined regions anneal to DDp418 and ﬂanking
regions are homologous to ChrXV-L). A second round of PCR with
the following primers extended homology to the ChrXV-L region:
CAN1-URA3 F2: 59-TAT TGT GAA TTG AAA TTT AAA GTT ATC
TCA AAT TCA AAT GAA TCT GCC GTT TCG ATT TAC-39 and
CAN1-URA3 R2:5 9-AGA TGG CTT TTC CAT CAG AGC CAT TGT
GAA GAA ATC GGA GGA AAA TTG TGG TCT ATT CAC-39
(underlined regions anneal to the PCR product from the ﬁrst
round). This ampliﬁed fragment was introduced in DDY642 to yield
DDY643 and was veriﬁed by PCR analysis. The MATa strain
(DDY644) used in the screen was derived from DDY643 by mating
type switching. All other strains were generated using genetic
crosses, via one-step disruptions or via transformation of the
indicated plasmids (see Table 4 for genotypes).
Screening procedure. To generate gene deletions in the ChrXV-L
GCR assay strain, we employed synthetic genetic array technology,
essentially as described by Tong et al. [16]. Brieﬂy, DDY644 was mated
to the MATa deletion strains from EUROSCARF (http://web.
uni-frankfurt.de/fb15/mikro/euroscarf/) on YPD and incubated at 30
8C overnight. Diploids were selected on SD-URAþ200 mg/L G418 and
incubated at 30 8C for 2 d. Sporulation proceeded on YE þ 0.05%
glucose for 7 d at 25 8C. Once sporulated, haploids were selected by a
four-step pinning procedure: two selections on SD-URA-HIS þ
cycloheximide (10 mg/L) followed by two selections on SD-URA-HIS
þ cycloheximide (10 mg/L) þ G418 (200 mg/L). Following the fourth
selection step, each deletion mutant was hand patched onto non-
selectiverichXYmedia(2%peptone,1%yeastextract,0.01%adenine,
and 0.02% tryptophan). Fourteen mutants in duplicate were patched
onto a single 10-cm plate. They were allowed to grow for 2 d at 30 8C
and were then replica plated onto agar plates to remove excess cells
priortoreplicaplatingontoFC(5-FOAandcan)media.FCplateswere
incubated for 3 d at 30 8C following replica plating and analyzed for
colony formation. Wild-type strains produced between 0–3 colonies
on average. Therefore, we scored a patch as a positive hit if the
threshold number of colonies per patch were equal to or greater than
ten. Deletion mutants (1,160) were then placed in a ‘‘1 hit’’ category
(for those with one patch that displayed greater than ten colonies) or
were in a ‘‘2 hit’’ category (for those with both patches that showed
greater than ten colonies). The ‘‘2 hit’’ category list, which consisted of
273 mutants, was narrowed down by focusing on genes that are
expressed in the nucleus [31]. However, we did not discard any gene
deletion that had unknown localization data. These ﬁlters reduced the
number of positive hits to 125. Of these 125, we reconstructed 48
deletions in the DDY643 background. Once constructed and con-
ﬁrmed,thesemutantswerefrozenat 808CimmediatelyinSC-URAto
ensure retention of the CAN1-URA3 markers.
Measurement of GCRs. Strains were grown in SC-URA media to
select for the URA3-CAN1 ChrXV-L arm prior to streaking cells onto
nonselective rich media (XY). Single colonies were isolated and grown
in 5 ml of XY medium until saturation. For wild-type strains, 1 ml of
culture was spun down and plated onto a 10-cm FC plate and the
number of cells/ml was calculated. A ﬂuctutation test and the method
of the median [24] was used to assess GCR rate. Similarily, for the
ChrV-L GCR assay, a single colony was inoculated into 15 ml of XY
medium until saturation. These cells were spun down and plated onto
a 15-cm FC plate and the number of cells/ml was calculated. Again, a
ﬂuctuation test and the method of the median were used to measure
GCR rates. To assess the effects of pyridoxine supplementation on
genome stability, cells were grown in the absence or presence of 2 lg/
ml pyridoxine hydrochloride (Supelco; http://www.sigmaaldrich.com/).
Measurement of PLP by HPLC. Wild-type, bud16D, tpn1D,
sno1snz1D, and tpn1D sno1snz1D strains were grown in 100-ml cultures
of XY þ 2% glucose (with the exception of tpn1D sno1snz1D) to early
log phase (OD600 1.0). The cells were spun down and washed thrice
with 50 ml of cold double-distilled water to remove any external PLP.
Table 4. Yeast Strains Used in This Study
Strain Genotype
DDY642 MAT a cyh2 can1D::MFA1pr-HIS3 leu2D0 ura3D0 his3D0 LYS2 TRP1
DDY643 MAT a ChrXV::CAN1-URA3 cyh2 can1D::MFA1pr-HIS3 leu2D0
ura3D0 his3D0 LYS2 TRP1
DDY644 MAT a ChrXV::CAN1-URA3 cyh2 can1D::MFA1pr-HIS3 leu2D0
ura3D0 his3D0 LYS2 TRP1
DDY832 DDY643 rad5D::KAN
DDY834 DDY643 slx8D::KAN
DDY838 DDY643 rmi1D::KAN
DDY840 DDY643 hex3D::KAN
DDY863 DDY643 rml2D::KAN
DDY884 DDY643 bud16D::KAN
DDY886 DDY643 esc2D::KAN
DDY890 DDY643 wss1D::KAN
DDY907 DDY643 rad52D::KAN
DDY913 DDY643 rad6D::KAN
DDY914 DDY643 rad27D::KAN
DDY916 DDY643 mre11D::KAN
DDY917 DDY643 sgs1D::KAN
DDY926 DDY643 rad18D::KAN
DDY928 DDY643 rad51D::KAN
DDY1095 DDY643 zip1D::KAN
DDY1186 DDY643 snz1D::KAN
DDY1344 DDY643 rad52D::NAT bud16D::KAN
DDY1391 DDY644 bud16D::NAT
DDY1489 DDY643 tpn1D::KAN
DDY1445 DDY643 sno1snz1D::LEU2
DDY1499 DDY643 bud16D::NAT tpn1D::KAN
DDY1522 DDY643 ung1D::KAN
DDY1676 DDY643 tpn1D::KAN sno1snz1D::LEU2
DDY1677 DDY643 ung1D::KAN bud16D::NAT
DDY1669 DDY643 bud16D::NAT rad9D::KAN
DDY145 MATa ura3–52 leu2D1 trp1D63 his3D200 lys2DBgl hom3–10
ade2D1 ade8 YEL069::URA3
DDY1670 DDY145 bud16D::KAN
All strains used are in the S288C (BY4741) background and were made for this study, with
the exception of DDY145 which was a kind gift of R. Kolodner.
doi:10.1371/journal.pgen.0030134.t004
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were clariﬁed by centrifugation at high speed to remove cell debris.
PLP measurements were done blindly at the diagnostic division of
Anticancer (http://www.anticancer.com/).
Rad52-YFP ﬂuorescent microscopy. We assessed Rad52-YFP focus
formation assay essentially as described by Lisby et al. [38] with the
following modiﬁcations. Three independent isolates of each strain
containing the pRAD52-YFP plasmid (a gift of Grant Brown) were
grown in SC-LEU. Cells were imaged on an Nikon Eclipse E600 FN
microscope (http://www.nikonusa.com) equipped with an ORCA ER2
camera (http://www.hamamatsu.com) and Chroma ﬁlters (http://www.
chroma.com/). Micrographs were taken in 21 z-stacks with 0.007-lm
increments. For each independent isolate, a minimum of 180 cells
were examined.
Mammalian cell culture. HeLa cells were grown in DMEM
supplemented with 10% fetal calf serum. SiHa cervical carcinoma
cells were obtained from the American Type Culture Collectin (http://
www.atcc.org) and maintained in exponential growth by twice-weekly
subcultivation in minimal essential medium containing 10% fetal
bovine serum (Gibco, http://www.invitrogen.com/). A stock solution of
4-DP (200 mM) was prepared in 0.9% saline, diluted in growth
medium, and adjusted to pH 7.2.
Western blotting and kinase assays. Human whole-cell extracts (25
lg) were prepared by boiling the cellular pellet in 13 SDS sample
buffer for 5 min. Extracts were loaded onto an SDS-PAGE gel and
after electrophoresis, proteins were transferred to a PVDF membrane
(Millipore, http://www.millipore.com/) and immunoblotted with either
the phospho-Chk2(Thr68) or Chk2 primary antibodies (Cell Signaling
Technology, http://www.cellsignal.com/) followed by horseradish
peroxidase-coupled secondary antibody (Jackson ImmunoResearch
Laboratories, http://www.jacksonimmuno.com/). Rad53 immunoblot-
ting and autokinase assays were carried out on denatured cell extracts
exactly as described previously [9,63].
Immunoﬂuorescence. HeLa cells grown on coverslips were washed
twice in PBS and ﬁxed with 2% PFA for 1 h at room temperature,
washed, and permeabilized with 1% Triton-X in PBS (1h, room
temperature) and subsequently blocked for an additional 1 h in 10%
antibody dilution buffer (10% normal goat serum, 3% BSA, and
0.05% Triton X in PBS). Monoclonal 53BP1 antibody (Transduction
Laboratories) was diluted in blocking buffer and incubated with cells
overnight at room temperature followed by two 10 min washes in
0.05% Triton X-100 in PBS. The appropriate Alexa-555 conjugated
secondary antibody (Molecular Probes, http://probes.invitrogen.com/)
was diluted 1:500 in 10% antibody dilution buffer and incubated with
the coverslips for 2 h at room temperature. After several washes with
PBS, the cells were stained with DAPI (10 lg/ml) for 20 min and
mounted with ProLong Gold anti-fade agent (Molecular Probes).
Pulse-ﬁeld gel electrophoresis. Brieﬂy, ;1310
8 cells grown from a
saturated culture were spun down, washed, and then resuspended in
TE (pH 7.5) and Zymolyase (Zymo Research, http://www.zymoresearch.
com. Plugs were formed by mixing liqueﬁed low melt agarose
(SeaKem; http://www.lonza.com) with the resuspended cells and
solidiﬁed in plug molds. Plugs were transferred into LET solution
(0.5M EDTA pH 8.0, 0.01M Tris-HCl (pH 7.5), 40mM DTT, and 0.4mg/
ml Zymolyase) overnight at 37 8C. Plugs were then transferred into
fresh tubes containing NDS solution (0.5 M EDTA pH 9.5, 0.01 M
Tris-HCl pH 7.5, 1% N-lauroyl sarcosine sodium salt, and 2 mg/ml
proteinase K) and incubated at 50 8C overnight. Plugs were washed
several times in TE (pH 7.5) and incubated for 1 h. Plugs containing
whole chromosomes were immediately run on a CHEF-DR III system
(Bio-Rad, ttp://www.bio-rad.com/) using a 1% agarose gel and 0.53
TBE at 14 8C, switch time 6–120 s, angle 1208 for 24 h with a voltage
gradient of 6V/cm. To examine the size of the terminal restriction
fragment on ChrXV-L, whole chromosomes were prepared as
described above in agarose plugs and were then digested with the
restriction enzyme PmeI. Plugs of digested chromosomes were run on
a 1% agarose gel in 0.53TBE at 14 8C, switch time 1–15 s, angle 1208,
19 h with a voltage gradient of 6V/cm.
Flow cytometry and cell size. SiHa cells (5 3 10
5) were ﬁxed in 1.4
ml of 70% ethanol and kept at  208 C for up to two weeks before
analysis. All ﬁxed samples were prepared for antibody staining and
analyzed on the same day. One milliliter of cold Tris-buffered saline,
pH 7.4 (TBS) was added to each tube, then the cells were spun down
and resuspended in 1 ml of cold 4% FBS and 0.1% Triton X-100
(TST) and placed on ice. Cells were allowed to rehydrate for 10 min,
then spun down and resuspended in 200 ll of mouse monoclonal
anti-phospho-histone H2A.X antibody (Upstate Biotechnology http://
www.millipore.com/), which was diluted 1:500 in TST. Tubes were
incubated on a shaker for 2 h at room temperature, rinsed with cold
TST, and resuspended in 200 ul of secondary antibody (Alexa 488
goat antimouse IgG [H þ L]F[ab9]2 fragment conjugate [Molecular
Probes] diluted 1:200 in TST) for 1 h at room temperature. Cells were
rinsed in 2% FBS in TBS and resuspended in 400 ll of cold TBS
containing 1 lg/ml DAPI. Samples were analyzed using a Coulter Elite
dual laser ﬂow cytometer (http://www.beckmancoulter.com). List
mode ﬁles were analyzed using WinList software (Verity Software
House, http://www.vsh.com/).
Uracil detection. DNA was isolated from yeast strains using Qiagen
(http://www.qiagen.com) gravity tip columns as per the manufac-
turer’s protocol and assayed for uracil incorporation as described in
Cabelof et al. [64]. Brieﬂy, 4 lg of DNA was blocked for 2 h at 37 8Ci n
a2 3 tris/methoxyamine buffer (ﬁnal concentration: 100 mM
methoxyamine [Sigma-Aldrich, http://www.sigmaaldrich.com/] and
50 mM Tris-HCl, pH 7.4). DNA was precipitated with 7.5% volumes
of 4 M NaCl and 4 volumes of ice-cold 100% ethanol and
resuspended in TE buffer, pH 7.6. DNA was then treated with 0.4
units of Uracil DNA Glycosylase (New England Biolabs, http://www.
neb.com) for 15 min at 37 8C, immediately precipitated, and
resuspended in TE buffer, pH 7.6. DNA was then probed with 2
mM aldehydic reactive probe (Dojindo Molecular Technology, http://
dojindo.com/) for 15 min at 37 8C followed by ethanol precipitation
and resuspension in TE buffer, pH 7.6. DNA was then heat denatured,
immobilized onto a nitrocellulose membrane (Schleicher and Schuell,
http://www.whatman.com/), and baked under vacuum as originally
described by Nakamura et al. [48]. The dried membrane was washed
in 53 SSC for 15 min at 37 8C, then incubated in a prehybridization
buffer (20 mM Tris, pH 7.5; 0.1 M NaCl; 1 mM EDTA; 0.5% casein w/v;
0.25%BSA w/v; and 0.1% Tween-20 v/v) for 30 min at room
temperature. Streptavidin-POD conjugate (Roche, http://www.roche.
com/) was added at a 1:2,000 dilution for 45 min at room temperature.
Membrane was washed in TBS/Tween-20 three times at 37 8C,
incubated in ECL solution (Pierce, http://www.piercenet.com/) for 5
min at room temperature, then visualized and quantiﬁed using a
ChemiImagerTM system (Alpha Innotech, http://www.alphainnotech.
com/). Data are expressed as the integrated density value of the band
per microgram of DNA loaded on the membrane.
Comparative genome hybridization. Yeast genomic DNA was
prepared from saturated 10-ml cultures essentially by the method
of [65]. Genomic DNA (2 lg) was digested for 2 h with 10 U of HaeIII
and puriﬁed by phenol-chloroform extraction and ethanol precip-
itation. HaeIII-digested genomic DNA (50 lg) was labeled and
hybridized by the method of [66]. Brieﬂy, after blunting the DNA
ends with T4 polymerase, the fragments were ligated to unidirec-
tional linkers and ampliﬁed by ligation-mediated PCR in the
presence of aminoallyl-modiﬁed dUTP. Indirect labeling was per-
formed using monoreactive Cy5 (for the parental strain) or Cy3
(strains that had undergone GCR) NHS esters that react speciﬁcally
with the aminoallyl-dUTP. Control and experimental samples were
combined, and the labeled DNA was hybridized to a yeast whole-
genome ChIP-on-chip microarray (4 3 44K; Agilent Technologies,
http://www.home.agilent.com/) and scanned at the University Health
Network Microarray Centre (http://www.microarrays.ca/). Microarray
images were processed with GenePix Pro 6.0 (Molecular Devices,
http://www.moleculardevices.com). Data were analysed as described
previously [67]. Hybridization data were preprocessed with ArrayPipe
1.7 [68], the background was subtracted using the ‘‘foreground-
background’’ correction method, the data were normalized using the
‘‘linear model for microarray analysis (limma) loess (subgrid)
method,’’ and the results were mapped using the University of
California Santa Cruz genome browser (http://genome.ucsc.edu/
cgi-bin/hgGateway).
Text S2 contains supplementary materials and methods for
apoptosis analysis, yeast DNA content, and cell size distributions.
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